GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Li, Meng ^a,b   Meng, Xiangyu ^a,b   Xu, Jie ^b   Huang, Xiuqing ^b   Li, Hongxia ^b   Li, Guoping ^b   Wang, Shu ^b   Man, Yong ^b   Tang, Weiqing ^b   Li, Jian ^a,b  

^a Chinese Academy of Medical Sciences   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GPR40 PROTEIN, MOUSE; GW9508; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIVER X RECEPTOR; METHYLAMINE; PROPIONIC ACID DERIVATIVE;

AGONISTS; ANIMAL; C57BL MOUSE; HEP-G2 CELL LINE; HUMAN; LIPID METABOLISM; LIVER; METABOLISM;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; HEP G2 CELLS; HUMANS; LIPID METABOLISM; LIVER; LIVER X RECEPTORS; METHYLAMINES; MICE, INBRED C57BL; PROPIONATES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84964851283     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25237     Document Type: Article

References (40)

1. Browning, J. D. & Horton, J. D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114, 147-152 (2004).
2. Sanyal, A. J. Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 46-53 (2005).
3. Peet, D. J. et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR? . Cell 93, 693-704 (1998).
4. Repa, J. et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289, 1524-1529 (2000).
5. Repa, J. J. & Mangelsdorf, D. J. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol. 16, 459-481 (2000).
6. Repa, J. J. & Mangelsdorf, D. J. The liver X receptor gene team: potential new players in atherosclerosis. Nat. Med. 8, 1243-1248 (2002).
7. Repa, J. J. et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXR? and LXR? . Gene Dev. 14, 2819-2830 (2000).
8. Horton, J. D., Goldstein, J. L. & Brown, M. S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131 (2002).
9. Schultz, J. R. et al. Role of LXRs in control of lipogenesis. Gene Dev. 14, 2831-2838 (2000).
10. Hirasawa, A. et al. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 11, 90-94 (2004).
11. Itoh, Y. et al. Free fatty acids regulate insulin secretion from pancreatic ? cells through GPR40. Nature 422, 173-176 (2003).
12. Wang, J., Wu, X., Simonavicius, N., Tian, H. & Ling, L. Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J. Biol. Chem. 281, 34457-34464 (2006).
13. Brown, A. J. et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312-11319 (2003).
14. Briscoe, C. P. et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 278, 11303-11311 (2003).
15. Suh, H. N., Huong, H. T., Song, C. H., Lee, J. H. & Han, H. J. Linoleic acid stimulates gluconeogenesis via Ca2+/PLC, cPLA2, and PPAR pathways through GPR40 in primary cultured chicken hepatocytes. Am. J. Physiol-cell. Ph 295, C1518-C1527 (2008).
16. Ou, H.-Y. et al. Multiple mechanisms of GW-9508, a selective G protein-coupled receptor 40 agonist, in the regulation of glucose homeostasis and insulin sensitivity. Am. J. Physiol-endoc. M 304, E668-E676 (2013).
17. Ou, H.-Y. et al. Activation of free fatty acid receptor 1 improves hepatic steatosis through a p38-dependent pathway. J. Mol. Endocrinol. 53, 165-174 (2014).
18. Jung, U. J., Millman, P. N., Tall, A. R. & Deckelbaum, R. J. n? 3 Fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice. Bba-mol. Cell Biol. L. 1811, 491-497 (2011).
19. Yan, Y. et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38, 1154-1163 (2013).
20. Maxwell, K. N., Soccio, R. E., Duncan, E. M., Sehayek, E. & Breslow, J. L. Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J. Lipid. Res. 44, 2109-2119 (2003).
21. Li, Y. et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376-388 (2011).
22. Hawley, S. A. et al. Calmodulin-dependent protein kinase kinase-α is an alternative upstream kinase for AMP-Activated protein kinase. Cell Metab. 2, 9-19 (2005).
23. Rhee, S. G. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70, 281-312 (2001).
24. Shapiro, H., Shachar, S., Sekler, I., Hershfinkel, M. & Walker, M. D. Role of GPR40 in fatty acid action on the ? cell line INS-1E. Biochem. Biophys. Res. Commun. 335, 97-104 (2005).
25. Tong, L. Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery. Cell Mol. Life Sci. 62, 1784-1803 (2005).
26. Hurley, R. L. et al. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-Activated protein kinase kinases. J. Biol. Chem. 280, 29060-29066 (2005).
27. Woods, A. et al. Ca2+/calmodulin-dependent protein kinase kinase-α acts upstream of AMP-Activated protein kinase in mammalian cells. Cell Metab. 2, 21-33 (2005).
28. Fujiwara, K., Maekawa, F. & Yada, T. Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet ?-cells: mediation by PLC and L-type Ca2+ channel and link to insulin release. Am. J. Physiol-endoc. M 289, E670-E677 (2005).
29. Hara, T., Hirasawa, A., Ichimura, A., Kimura, I. & Tsujimoto, G. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. J. Pharm. Sci. 100, 3594-3601 (2011).
30. Winzell, M. S. & Ahrén, B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol. Therapeut. 116, 437-448 (2007).
31. Zhang, Z. et al. Key regulatory oxysterols in liver: analysis as ? 4-3-ketone derivatives by HPLC and response to physiological perturbations. J. Lipid. Res. 42, 649-658 (2001).
32. Wouters, K. et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 48, 474-486 (2008).
33. Hutchinson, D. S., Summers, R. J. & Bengtsson, T. Regulation of AMP-Activated protein kinase activity by G-protein coupled receptors: potential utility in treatment of diabetes and heart disease. Pharmacol. Therapeut. 119, 291-310 (2008).
34. Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Bio 13, 251-262 (2012).
35. Nagasumi, K. et al. Overexpression of GPR40 in pancreatic ?-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice. Diabetes 58, 1067-1076 (2009).
36. Burant, C. F. et al. TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebocontrolled trial. Lancet 379, 1403-1411 (2012).
37. Steneberg, P., Rubins, N., Bartoov-Shifman, R., Walker, M. D. & Edlund, H. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab. 1, 245-258 (2005).
38. Lan, H. et al. Lack of FFAR1/GPR40 does not protect mice from high-fat diet-induced metabolic disease. Diabetes 57, 2999-3006 (2008).
39. Temel, R. E. et al. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J. Clin. Invest. 117, 1968-1978 (2007).
40. Ye, J. et al. Cideb, an ER-And lipid droplet-Associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. Cell Metab. 9, 177-190 (2009).